Le Lézard
Classified in: Health
Subjects: AWD, CHI, CSR, FVT

Blood Science Foundation Shines Light On Outstanding Chicagoland Youth, Announces Finalists For Inaugural NextUp Awards


CHICAGO, Feb. 19, 2019 /PRNewswire/ -- Blood Science Foundation, the fundraising and philanthropic arm of Vitalant (formerly LifeSource), is preparing to honor some of Chicagoland's outstanding youth by hosting the organization's first edition of The NextUp Awards.

Launched this winter, the NextUp Awards provides scholarships to deserving young people across the area who have shown a transformative commitment to their communities ? through fundraising, the development of charitable programs, volunteering, leadership and philanthropy.

Finalists, their families and community leaders will gather for the official awards ceremony on March 12 at the Art Institute of Chicago, where Blood Science Foundation will announce the winners.    

"Throughout Chicago, determined young people are looking beyond themselves and doing good in their communities," said Sunny Chico, board member, Blood Science Foundation and co-chair, The NextUp Awards. "At Blood Science Foundation, we believe it is vital to give them the recognition that they deserve. That's why we launched the NextUp Awards."

"The very best of our youngest generation is taking ownership of their futures," added Mark Giaquinto, president and chief financial officer, Blood Science Foundation. "They realize it's about the good they can do for others, which can create a ripple effect and set an example for the entire region."

School districts, organizations and students themselves had the opportunity to nominate young people for the awards program. Nominees were required to live within the Vitalant service area in Chicagoland and had to have completed a charitable or philanthropic activity in the past 18 months that could be replicated in other cities.

A committee chosen by Blood Science Foundation selected three finalists from each of the age categories. One winner in each category will receive a $2,500 scholarship.

The 2019 finalists listed by category are:

Age 12 and under

Ages 13-15

Ages 16-18

Event sponsors include AON, Nixon Peabody, Drinker Biddle & Reath, Flexan, Hall Render, PNC and Swedish Covenant Health. For more information and to purchase tickets to attend the NextUp Awards, please click here.

Note to editors & reporters: Media are invited to attend. To arrange interviews or for information, please contact Jeff Jones at 412-642-7700 or [email protected].   

About Blood Science Foundation

Blood Science Foundation is the philanthropic arm of Vitalant's blood bank operations in greater Pittsburgh and in Chicagoland. Through fundraising and public education efforts, Blood Science Foundation supports the life-saving mission of these blood banks ? to provide an adequate blood supply to their hospital and health care customers so doctors can perform surgeries, treat critically injured patients and help others fight diseases. Blood Science Foundation also funds vital research aimed at curing blood-related diseases and ensuring a safe blood supply. For more information, visit www.bloodsciencefoundation.org.

MEDIA CONTACT:
Jeff Jones
(412) 642-7700
[email protected]

SOURCE Blood Science Foundation


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: